In The Press

In The Press2024-03-14T15:54:08-08:00
1403, 2024

Phyton shares new article published by iScience that demonstrates that QS-21 produced via plant cell culture for saponin-derived vaccine adjuvants can be commercially produced in a sustainable way

March 14th, 2024|

Phyton Biotech is pleased to announce a recent publication by iScience showcasing the successful application of its plant cell fermentation platform to derive an important compound.

Go to Top